Carbamic acid, [(1S,2S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester

InChIKey	`QNMCBWIGCQHDEC-SPRQWYLLSA-N`
Compound Name	Carbamic acid, [(1S,2S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester
Canonical SMILES	`Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Homologous
Avg pChEMBL	10.15
Source	BindingDB;ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P04585	gag-pol	Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)	Pathogen	PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098	10.4	Ki	BindingDB
Q72874	pol	Human immunodeficiency virus type 1	Pathogen	PF00077	10.4	Ki	ChEMBL
Q9YQ12	protease	Human immunodeficiency virus type 1	Pathogen	PF00077	9.6	Ki	ChEMBL;BindingDB